Bauer T, Ewig S, Schäfer H, Jelen E, Lüderitz B
Berufsgenossenschaftliche Kliniken Bergmannsheil-Universitätsklinik, Ruhr-Universität, Bochum.
Pneumologie. 1997 Aug;51 Suppl 3:736-9.
The increased mortality among patients with obstructive sleep apnoea syndrome has been explained in part by the increased incidence of pulmonary hypertension and coronary artery disease (CAD). A decreased heart rate variability has been shown to be associated with an increased mortality as well. We therefore screened 53 patients for sleep-related breathing disorders (SRBD) and heart rate variability (HRV) during the sleeping period. Standard time domain parameters were compared in a univariate multifactorial model for patients with an oxygen desaturation index (ODI) of more or less than 5 including the factors CAD, diabetes and beta-blocker use. The percentage of differences between RR-intervals that differ more than 50 ms (pNN > 50: 9.0 +/- 11.1% vs 19.2 +/- 22.2%; p < 0.05) as well as the root mean square of these differences (rMSSD: 38.0 +/- 29.0 msec vs 59.2 +/- 51.5 msec; p < 0.05) were significantly decreased in patients with SRBD. These results favour HRV for inclusion in future risk stratification models in patients with sleep-related breathing disorders.
阻塞性睡眠呼吸暂停综合征患者死亡率增加,部分原因是肺动脉高压和冠状动脉疾病(CAD)发病率上升。心率变异性降低也与死亡率增加有关。因此,我们对53例患者在睡眠期间的睡眠相关呼吸障碍(SRBD)和心率变异性(HRV)进行了筛查。在单变量多因素模型中,对氧饱和度下降指数(ODI)大于或小于5的患者的标准时域参数进行了比较,这些因素包括CAD、糖尿病和β受体阻滞剂的使用。RR间期差异超过50毫秒的百分比(pNN>50:9.0±11.1%对19.2±22.2%;p<0.05)以及这些差异的均方根(rMSSD:38.0±29.0毫秒对59.2±51.5毫秒;p<0.05)在SRBD患者中显著降低。这些结果支持将HRV纳入未来睡眠相关呼吸障碍患者的风险分层模型。